Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation

Roger S. McIntyre(University of Toronto), Stephen M. Stahl(Champalimaud Foundation), Mehala Subramaniapillai(Sunnybrook Health Science Centre), Jung Goo Lee(Kyungsung University), Rodrigo B. Mansur(University Health Network), Kevin Kratiuk(Brain and Cognition Discovery Foundation), Gerard Sanacora(Yale University), Philip Gorwood(Inserm), Seetal Dodd, George I. Papakostas(Harvard University), Siegfried Kasper(Medical University of Vienna), Dan V. Iosifescu(Nathan Kline Institute for Psychiatric Research), Charles B. Nemeroff(The University of Texas at Austin), Joshua D. Rosenblat(University Health Network), Allan H. Young(King's College London), Eduard Vieta(Hospital Clínic de Barcelona), Roger Ho(National University of Singapore), Carlos López‐Jaramillo(Universidad de Antioquia), Elisa Brietzke(Queen's University), Michael Berk(The Royal Melbourne Hospital), Yena Lee(Sunnybrook Health Science Centre), Michael E. Thase(Veterans Health Administration), Leanna M.W. Lui(Sunnybrook Health Science Centre), Carlos A. Zarate(National Institute of Mental Health), James W. Murrough(Allen Institute for Brain Science)
American Journal of Psychiatry
March 17, 2021
Cited by 707


Related Papers